PD-L1对人口腔鳞状细胞癌细胞增殖、迁移和侵袭的影响

曾洁,俞雪燕,罗婷,徐江

PDF(1199 KB)
PDF(1199 KB)
吉林大学学报(医学版) ›› 2024, Vol. 50 ›› Issue (1) : 18-24. DOI: 10.13481/j.1671-587X.20240103
基础研究

PD-L1对人口腔鳞状细胞癌细胞增殖、迁移和侵袭的影响

  • 曾洁1,俞雪燕2,罗婷3,徐江1()
作者信息 +

Effect of PD-L1 on proliferation, migration, and invasion of human oral squamous carcinoma cells

  • Jie ZENG1,Xueyan YU2,Ting LUO3,Jiang XU1()
Author information +
History +

摘要

目的 探讨程序性细胞死亡配体1(PD-L1)在口腔鳞状细胞癌(OSCC)细胞中的表达及其对OSCC CAL27细胞生物学行为的影响,阐明其可能的作用机制。 方法 采用Western blotting法检测口腔上皮HOK细胞和OSCC CAL27、TCA8113和SCC15细胞中PD-L1蛋白表达水平。免疫荧光染色法检测CAL27细胞中PD-L1蛋白表达和定位情况。将CAL27细胞分为对照组(转染si-NC)和si-PD-L1组(转染si-PD-L1),Western blotting法检测2组细胞干扰效率,CCK-8法检测不同时间点2组细胞增殖活性,平板克隆实验检测2组细胞克隆形成数,细胞划痕愈合实验检测2组细胞划痕愈合率,Transwell小室实验检测2组细胞中迁移和侵袭细胞数。 结果 OSCC细胞中PD-L1蛋白表达水平均高于HOK细胞(P<0.05或P<0.01),PD-L1在CAL27细胞的细胞质和细胞核中均有表达。CCK-8法和平板克隆实验,与对照组比较,不同时间点si-PD-L1组CAL27细胞增殖活性明显降低(P<0.05或P<0.01),克隆形成数明显减少(P<0.01)。细胞划痕愈合实验,与对照组比较,si-PD-L1组CAL27细胞划痕愈合率明显降低(P<0.05或P<0.01)。Transwell小室实验,与对照组比较,si-PD-L1组CAL27细胞中迁移和侵袭细胞明显减少(P<0.01)。 结论 PD-L1在OSCC细胞中的表达高于口腔正常上皮细胞,敲低PD-L1表达可抑制OSCC细胞增殖、克隆形成及迁移和侵袭能力。

Abstract

Objective To discuss the expression of programmed cell death-ligand 1 (PD-L1) in the oral squamous cell carcinoma (OSCC) cells and its effect on biological behavior of the OSCC CAL27 cells, and to clarify the possible mechanism. Methods Western blotting method was used to detect the expression levels of PD-L1 protein in the oral epithelial HOK cells and OSCC CAL27, TCA8113, and SCC15 cells; immunofluorescence staining method was used to detect the expression and localization of PD-L1 protein in the CAL27 cells. The CAL27 cells were divided into control group (transfected with si-NC) and si-PD-L1 group (transfected with si-PD-L1). Western blotting method was used to detect the interference efficiency of the cells in two groups; CCK-8 assay was used to detect the proliferative activities of the cells in two groups at different time points; plate clone formation assay was used to detect the numbers of clone formation of the cells in two groups; cell scratch healing assay was used to detect the scratch healing rates of the cells in two groups; Transwell chamber assay was used to detect the numbers of migration and invasion cells in two groups. Results The expression level of PD-L1 protein in the OSCC cells was higher than that in the HOK cells (P<0.05 or P<0.01); PD-L1 expressed in the cytoplasm and nucleus of the CAL27 cells. The CCK-8 assay and plate clone formation assay results showed that compared with control group, the proliferative activities of the CAL27 cells in si-PD-L1 group at different time points were significantly decreased(P<0.05 or P<0.01), and the numbers of clone formation were significantly decreased (P<0.01). The cell scratch healing assay results showed that compared with control group, the scratch healing rates of the cells in si-PD-L1 group were significantly decreased (P<0.05 or P<0.01). The Transwell chamber assay results showed that compared with control group, the numbers of migration and invasion cells in si-PD-L1 group were significantly decreased (P<0.01). Conclusion The expression of PD-L1 in the OSCC cells is higher than that in normal oral epithelial cells, and knocking down PD-L1 expression can inhibit the proliferation, clone formation, migration and invasion capabilities of the OSCC cells.

关键词

口腔鳞状细胞癌 / 程序性细胞死亡配体1 / 细胞增殖 / 细胞迁移 / 细胞侵袭

Key words

Oral squamous cell carcinoma / Programmed cell death-ligand 1 / Cell proliferation / Cell migration / Cell invasion

中图分类号

R739.8

引用本文

导出引用
曾洁,俞雪燕,罗婷,徐江. PD-L1对人口腔鳞状细胞癌细胞增殖、迁移和侵袭的影响. 吉林大学学报(医学版). 2024, 50(1): 18-24 https://doi.org/10.13481/j.1671-587X.20240103
Jie ZENG,Xueyan YU,Ting LUO,Jiang XU. Effect of PD-L1 on proliferation, migration, and invasion of human oral squamous carcinoma cells[J]. Journal of Jilin University(Medicine Edition). 2024, 50(1): 18-24 https://doi.org/10.13481/j.1671-587X.20240103

参考文献

1 CHAVES F N, BEZERRA T M M, MORAES D C, et al. Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma[J]. Exp Mol Pathol, 2020, 112: 104341.
2 李玮柏, 曹 娟, 郭 秀, 等. 肿瘤相关巨噬细胞来源IL-6通过上调肿瘤细胞中LIF表达对口腔鳞状细胞癌CAL27细胞侵袭和迁移的促进作用[J]. 吉林大学学报(医学版), 2022, 48(4): 946-953.
3 PRINCIPE S, ZAPATER-LATORRE E, ARRIBAS L,et al. Salivary IL-8 as a putative predictive biomarker of radiotherapy response in head and neck cancer patients[J]. Clin Oral Investig, 2022, 26(1): 437-448.
4 DAVE K, ALI A, MAGALHAES M. Increased expression of PD-1 and PD-L1 in oral lesions progressing to oral squamous cell carcinoma: a pilot study[J]. Sci Rep, 2020, 10(1): 9705.
5 CROCE C M. Causes and consequences of microRNA dysregulation in cancer[J].Nat Rev Genet,2009,10(10): 704-714.
6 YU Y, CAO X C. miR-190-5p in human diseases[J]. Cancer Cell Int, 2019, 19: 257.
7 田国永, 鹿国英, 吕志军, 等. PD-1、PD-L1在口腔鳞状细胞癌中表达意义及对疾病预后价值研究[J]. 实用口腔医学杂志, 2021, 37(6): 841-844.
8 ZHANG Y H, WANG A F, ZHANG X H, et al. lncRNA LINC01296 promotes oral squamous cell carcinoma development by binding with SRSF1[J]. Biomed Res Int, 2021, 2021: 6661520.
9 SUN S, WANG J, LIU J, et al. miR-302b suppresses tumor metastasis by targeting Frizzled6 in OSCC[J]. J Dent Res, 2021, 100(7): 739-745.
10 CHA J H, CHAN L C, LI C W, et al. Mechanisms controlling PD-L1 expression in cancer[J]. Mol Cell, 2019, 76(3): 359-370.
11 WHITESIDE T L. Head and neck carcinoma immunotherapy: facts and hopes[J]. Clin Cancer Res, 2018, 24(1): 6-13.
12 JIANG Y S, CHEN M, NIE H, et al. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations[J].Hum Vaccin Immunother,2019,15(5):1111-1122.
13 TANG Q, CHEN Y, LI X J, et al. The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers[J]. Front Immunol, 2022, 13: 964442.
14 ZHENG B X, REN T T, HUANG Y, et al. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3[J]. Biochem Biophys Res Commun, 2018, 495(2): 1695-1701.
15 NIU M K, LIU Y M, YI M, et al. Biological characteristics and clinical significance of soluble PD-1/PD-L1 and exosomal PD-L1 in cancer[J]. Front Immunol, 2022, 13: 827921.
16 HU X L, WANG J, CHU M, et al. Emerging role of ubiquitination in the regulation of PD-1/PD-L1 in cancer immunotherapy[J]. Mol Ther, 2021, 29(3): 908-919.
17 程 然, 徐小元. PD-1/PD-L1免疫抑制剂在HBV感染相关肝细胞癌中的有效性及安全性分析[J]. 临床肝胆病杂志, 2022,38(9): 2160-2164.
18 李 林, 杨双宁, 秦国慧, 等. 基于UHPLC-Q-Orbitrap HRMS的PD-1抑制剂治疗的晚期肺腺癌患者血清代谢组学研究[J]. 郑州大学学报(医学版), 2022,57(5): 631-634.
19 LIU S W, CHEN S, YUAN W G, et al. PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways[J]. Oncotarget, 2017, 8(59): 99901-99912.
20 MU L S, YU W T, SU H L, et al. Relationship between the expressions of PD-L1 and tumour-associated fibroblasts in gastric cancer[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 1036-1042.
21 赵丽丽, 赵文文, 赵文飞, 等. 沉默PD-L1基因表达抑制胃癌细胞黏附、迁移、侵袭及上皮间质转化[J]. 现代肿瘤医学, 2022, 30(15): 2716-2722.
22 QU Q X, XIE F, HUANG Q, et al. Membranous and cytoplasmic expression of PD-L1 in ovarian cancer cells[J]. Cell Physiol Biochem,2017,43(5):1893-1906.
23 YANG S J, ZHANG Q Y, LIU S, et al. PD-1, PD-L1 and PD-L2 expression in mouse prostate cancer[J]. Am J Clin Exp Urol, 2016, 4(1): 1-8.

基金

国家自然科学基金项目(82160572)

评论

PDF(1199 KB)

Accesses

Citation

Detail

段落导航
相关文章

/